LONDON & BRISBANE, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an ...
DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Trelegy Ellipta" report has been added to ResearchAndMarkets.com's offering. Trelegy Ellipta ([fluticasone furoate + vilanterol + umeclidinium bromide]; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback